SEC Filings

Filing date	Form	Description	View
11/08/21	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001558370-21-014907.pdf 0001558370-21-014907.rtf 0001558370-21-014907.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
05/06/22	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001558370-22-007651.pdf 0001558370-22-007651.rtf 0001558370-22-007651.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
08/08/22	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001558370-22-012666.pdf 0001558370-22-012666.rtf 0001558370-22-012666.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
11/09/22	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001558370-22-017048.pdf 0001558370-22-017048.rtf 0001558370-22-017048.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
05/10/23	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001558370-23-008951.pdf 0001558370-23-008951.rtf 0001558370-23-008951.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
08/09/23	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001558370-23-014070.pdf 0001558370-23-014070.rtf 0001558370-23-014070.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
11/09/23	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001558370-23-018612.pdf 0001558370-23-018612.rtf 0001558370-23-018612.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
05/18/23	10-Q/A	Amendment to a previously filed 10-Q	View HTML 0001558370-23-010149.pdf 0001558370-23-010149.rtf 0001558370-23-010149.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
04/14/23	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-000113.pdf 0001950047-23-000113.rtf 0001950047-23-000113.xls
05/15/23	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-000626.pdf 0001950047-23-000626.rtf 0001950047-23-000626.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.